(Q39533603)

English

Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.

scientific article published on January 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

carcinoid tumor

1 reference

based on heuristic

inferred from title

author name string

B Wiedenmann

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

U Räth

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

R Rädsch

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

F Becker

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

B Kommerell

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Klinische Wochenschrift

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

75-77

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin localization in tissues.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin, gastrointestinal peptides, and the carcinoid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colorimetric assay of urinary 5-hydroxy-3-indoleacetic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of metastatic vipoma with somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2894481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01713015

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39533603&oldid=1587793932"